Skip to main content
Log in

Establishment of Two Glioma Cell Lines from Two Surgical Specimens Obtained at Different Times from the Same Individual

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

We established two glioma cell lines from two surgical specimens obtained at different times from the same patient. One (No. 9R), which was derived from the recurrent tumor (glioblastoma, grade IV), proliferated more rapidly in vitro than the other (No. 9) from the primary tumor (slightly anaplastic astrocytoma, grade II–III). No. 9R showed heterotransplantability in nude mice, whereas No. 9 did not. These findings indicate that No. 9R has a more aggressive or malignant nature than No. 9. Both cell lines showed homozygous deletion of the representative tumor suppressor p16 and p15 genes, but no p53 gene alteration. However, examination of the overall mRNA expression profile using a commercially available cDNA-spotted membrane revealed much higher expression levels of several mRNAs, at least, in No. 9R than in No. 9, although the relationship between these mRNAs and the growth potentials remained unknown. These two cell lines, derived from the same individual, with different proliferating potentials may be useful for studies on the molecular bases of glioma malignancy and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. The Committee of Brain Tumor Registry of Japan: Special issue. Neurol Med Chir (Tokyo) 32: 391–417, 1992

    Google Scholar 

  2. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas.Asimple and reproducible method. Cancer 62: 2152–2165, 1988

    PubMed  Google Scholar 

  3. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. Springer-Verlag, 1993, ed 2, pp 11–14

  4. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. London, Edward Arnold, 1977, ed 4, pp p146–244

    Google Scholar 

  5. Hayashi Y, Yamashita J, Yamaguchi K:Timing and role of p53 gene mutation in the recurrence of glioma. Biochem Biophys Res Commun 180: 1145–1150, 1991

    PubMed  Google Scholar 

  6. Koga H, Zhang SJ, Kumanishi T, Washiyama K, Ichikawa T, Tanaka R, Mukawa J: Analysis of p53 gene mutations in low-and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol 87: 225–232, 1994

    PubMed  Google Scholar 

  7. Louis DN, von Deimling A, Chung RY, Rubio M-P, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR: Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31–38, 1992

    Google Scholar 

  8. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313–1318, 1991

    PubMed  Google Scholar 

  9. Zhang SJ, Feng XL, Koga H, Ichikawa T, Abe S, Kumanishi T: p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Commun 196: 851–857, 1993

    PubMed  Google Scholar 

  10. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brainumors. Cancer Res 54: 6353–6358, 1994

    PubMed  Google Scholar 

  11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440, 1994

    PubMed  Google Scholar 

  12. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753–756, 1994

    PubMed  Google Scholar 

  13. Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321–6324, 1994

    PubMed  Google Scholar 

  14. Onda K, Tanaka R, Washiyama K, Takeda N, Kumanishi T: Correlation of DNA ploidy and morphological features of human glioma cell cultures with the establishment of cell lines. Acta Neuropathol 76: 433–440, 1988

    PubMed  Google Scholar 

  15. Harris M: Quantitative growth studies with chick myoblasts in glass substrate cultures. Growth 21: 149–166, 1957

    PubMed  Google Scholar 

  16. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766–2770, 1989

    PubMed  Google Scholar 

  17. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427–428, 1991

    PubMed  Google Scholar 

  18. Kumanishi T, Zhang SJ, Ichikawa T, Endo S, Washiyama K: Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions. Jpn J Cancer Res 87: 691–695, 1996

    PubMed  Google Scholar 

  19. Zhang SJ, Endo S, Koga H, Ichikawa T, Feng XL, Onda K, Washiyama K, Kumanishi T: A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations. Jpn J Cancer Res 87: 900–907, 1996

    PubMed  Google Scholar 

  20. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396–3397, 1994

    PubMed  Google Scholar 

  21. Usui H, Ichikawa T, Miyazaki Y, Nagai S, Kumanishi T: Isolation of cDNA clones of the rat mRNAs expressed preferentially in the prenatal stages of brain development. Develop Brain Res 97: 185–193, 1996

    Google Scholar 

  22. Bigner DD, Bigner SH, Pont´en J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. JNeuropathol Exp Neurol 40: 201–229, 1981

    Google Scholar 

  23. Maunoury R: Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol 39: 33–41, 1977

    PubMed  Google Scholar 

  24. Pont´en J, Macintyre EH: Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74: 465–486, 1968

    PubMed  Google Scholar 

  25. Rutka JT, Giblin JR, Dougherty DY, Liu HC, McCulloch JR, Bell CW, Stern RS, Wilson CB, Rosenblum ML: Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 75: 92–103, 1987 254

    PubMed  Google Scholar 

  26. Studer A, de Tribolet N, Diserens AC, Gaide AC, Matthieu JM, Carrel S, Stavrou D: Characterization of four human malignant glioma cell lines. Acta Neuropathol 66: 208–217, 1985

    PubMed  Google Scholar 

  27. Westermark B, Pont´en J, Hugosson R: Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand 81: 791–805, 1973

    Google Scholar 

  28. Allalunis-Turner MJ, Barron GM, Day III RS, Dobler KD, Mirzayans R: Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134: 349–354, 1993

    PubMed  Google Scholar 

  29. Eliyahu D, Michalovitz D, Oren M: Overproduction of p53 antigen makes established cells highly tumorigenic. Nature 316: 158–160, 1985

    PubMed  Google Scholar 

  30. Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, Noble MD: Retinoblastoma gene deletions in human glioblastomas. Oncogene 6: 445–448, 1991

    PubMed  Google Scholar 

  31. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis G, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275: 1943–1947, 1997

    Google Scholar 

  32. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Lignon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356–362, 1997

    PubMed  Google Scholar 

  33. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ulrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147, 1985

    PubMed  Google Scholar 

  34. Mørk SJ, Laerum OD: DNA distribution in human gliomas in vivo and in vitro. In: Laerum OD, Lindmo T, Thorud E(eds) Flow Cytometry IV. Universitetsforlaget, Oslo, pp 403–406

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Onda, K., Nagai, S., Tanaka, R. et al. Establishment of Two Glioma Cell Lines from Two Surgical Specimens Obtained at Different Times from the Same Individual. J Neurooncol 41, 247–254 (1999). https://doi.org/10.1023/A:1006172608019

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006172608019

Navigation